AI assistant
Oric Pharmaceuticals, Inc. — Director's Dealing 2022
Jul 21, 2022
32131_dirs_2022-07-21_c1fc6b2a-25a4-42af-8a7d-921a96b2557e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2022-07-20
Reporting Person: Chacko Jacob (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-07-20 | Stock Option (right to buy) | $16.00 | D | 437500 | Disposed | 2030-04-22 | Common Stock (437500) | Direct |
| 2022-07-20 | Stock Option (right to buy) | $29.83 | D | 280000 | Disposed | 2031-01-31 | Common Stock (280000) | Direct |
| 2022-07-20 | Stock Option (right to buy) | $9.48 | D | 300000 | Disposed | 2032-01-31 | Common Stock (300000) | Direct |
| 2022-07-20 | Stock Option (right to buy) | $4.36 | A | 437500 | Acquired | 2032-07-19 | Common Stock (437500) | Direct |
| 2022-07-20 | Stock Option (right to buy) | $4.36 | A | 280000 | Acquired | 2032-07-19 | Common Stock (280000) | Direct |
| 2022-07-20 | Stock Option (right to buy) | $4.36 | A | 300000 | Acquired | 2031-07-19 | Common Stock (300000) | Direct |
Footnotes
F1: Twenty five percent (25%) of the shares subject to the option vested on April 23, 2021, and one forty-eighth (1/48th) of the shares subject to the option vested each month thereafter.
F2: On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share.
F3: Twenty five percent (25%) of the shares subject to the option vested on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested each month thereafter.
F4: Twenty five percent (25%) of the shares subject to the option would have vested on February 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option would have vested each month thereafter.
F5: One-third (1/3rd) of the shares subject to the option shall vest on July 20, 2023, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter.
F6: Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.